This inventor holds 1 USPTO granted patent. Top assignee: University of Colorado. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Innovations in Deep Brain Stimulation by John Thompson
Introduction
John Thompson is an accomplished inventor based in Westminster, CO (US). He has made significant contributions to the field of neuroscience, particularly in the area of deep brain stimulation. His innovative work focuses on utilizing artificial neural networks to enhance treatment for patients with advanced Parkinson's Disease.
Latest Patents
John Thompson holds a patent for "Deep brain stimulation using artificial neural networks." This technology relates to closed-loop deep brain stimulation that is based on inferred sleep stages from physiological data using machine learning classifiers. The patent outlines various embodiments that may use subthalamic nucleus (STN) deep brain stimulation (DBS) to treat advanced Parkinson's Disease motor symptoms while also improving sleep quality. The system is designed to identify sleep stages that align with clinician-scored polysomnography (PSG). The DBS technology incorporates a novel artificial neural network (ANN) that triggers targeted stimulation in response to inferred sleep states derived from STN local field potentials (LFPs) recorded from implanted DBS electrodes. A feedforward neural network is trained to prospectively identify sleep stages with PSG-level accuracy. Additionally, the machine learning model stored within the DBS can adapt stimulation during specific sleep stages to address targeted sleep deficits. John Thompson has 1 patent to his name.
Career Highlights
John Thompson's career is marked by his dedication to advancing medical technology. His work has the potential to significantly improve the quality of life for individuals suffering from Parkinson's Disease. By integrating machine learning with deep brain stimulation, he is at the forefront of a transformative approach to neurological treatment.
Collaborations
John collaborates with notable colleagues, including Aviva Abosch and Joel Zylberberg. Their combined expertise contributes to the innovative research and development of advanced medical technologies.
Conclusion
John Thompson's contributions to deep brain stimulation through artificial neural networks represent a significant advancement in the treatment of Parkinson's Disease. His innovative approach has the potential to change the landscape of neurological therapies, offering hope to many patients.